Download PDF
Drug Res (Stuttg) 2016; 66(05): 257-261
DOI: 10.1055/s-0035-1569326
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Comparison of the Therapeutic Effects and Side Effects of Oral Iron Supplements in Iron Deficiency Anemia

T.-W. Wu
1   Department of Pharmacy, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan
,
F.-P. Tsai
1   Department of Pharmacy, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan
› Author Affiliations
Further Information

Publication History

received 11 May 2015

accepted 30 November 2015

Publication Date:
23 December 2015 (online)

Also available at
    Permissions and Reprints

Abstract

Objective: Iron deficiency anemia is an important public health issue, especially for infants, children, and women with menorrhagia. Oral iron supplements are the cheapest, safest, and most effective treatment. This study compared the therapeutic and side effects of ferrous and ferric in iron deficiency anemia.

Methods: This was a retrospective study on data collected between April 2012 and October 2013 for patients with iron deficiency anemia who continuously took oral ferric for over one month and then switched to oral ferrous due to poor therapeutic effects. The exclusion criteria were the use of other oral or injected iron preparations, erythropoietin, or vitamin B12.

Results: A total of 41 participants were recruited. The average participant age was 44.76±16.89 years; most participants were females (95.1%; 39/41); the average daily dose of oral ferric (139.02±49.39 mg) was higher than that of ferrous (96.34±23.43 mg). Repeated measures: mixed model analyses were conducted to examine patients’ clinical blood test values. The results showed that the mean blood test values for all patients significantly increased after switching to ferrous (p<0.01, with the exception of mean corpuscular hemoglobin). One patient experienced gastrointestinal discomfort and diarrhea after switching to ferrous.

Conclusion: This study found that blood test values improved after iron deficiency anemia female patients who displayed poor therapeutic effects with oral ferric switched to ferrous. Literature review showed that the risk for gastrointestinal problems with ferrous is higher than that with ferric. However, no significant difference was found in this study.

Key words

ferric - ferrous - malnutrition
 

  • References

  • 1 Adamson J. Iron deficience and other hypoproliferative anemias. In: Kasper DL, Braunwald E, Fauci AS, et al. (eds.). Harrison’s Principles of Internal Medicine. New York: McGraw Hill; 2005: 16
    Google Scholar
  • 2 Worldwide prevalence of anaemia. WHO Global database on anaemia. http://whqlibdoc.who.int/publications/2008/9789241596657eng.pdf 1993-2005
    PubMedGoogle Scholar
  • 3 UNICEF/UNU/WHO. Iron deficiency anemia: assessment, prevention, and control. Geneva, Switzerland: 2001
    Google Scholar
  • 4 Nissenson AR, Goodnough LT, Dubois RW. Anemia: not just an innocent bystander?. Archives of Internal Medicine 2003; 163: 1400-1404
    CrossrefPubMedGoogle Scholar
  • 5 Hercberg S, Preziosi P, Briançon S et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.Vi.Max study – design, methods, and participant characteristics. Controlled Clinical Trials 1998; 19: 336-351
    CrossrefPubMedGoogle Scholar
  • 6 Food & Drug Administration. Food & Drug Consumer Newsletter. 2010; 243: 1-2 http://www.fda.gov.tw/TC/PublishOtherEpaper.aspx?pn=33
    PubMedGoogle Scholar
  • 7 Heeney MM, Andrews NC. Iron homeostasis and inherited iron overload disorders: an overview. Hematology/Oncology Clinics of North America 2004; 18: 1379-1403
    CrossrefPubMedGoogle Scholar
  • 8 Bothwell TH, Charlton RW, Cook JD et al. Iron Metabolism in Man. Oxford, UK: Blackwell; 1979
    Google Scholar
  • 9 Miret S, Simpson RJ, McKie AT. Physiology and molecular biology of dietary iron absorption. Annual Review of Nutrition 2003; 23: 283-301
    CrossrefPubMedGoogle Scholar
  • 10 Kemna EHJM, Tjalsma H, Willems HL et al. Hepcidin: from discovery to differential diagnosis. Haematologica 2008; 93: 90-97
    CrossrefPubMedGoogle Scholar
  • 11 Stotzfus RJ, Deryfuss ML. Guidelines for the use of iron supplements to prevent and treat iron deficiency anaemia. International Nutritional Anaemia Consultative Group (INACG), World Health Organisation (WHO), United Nations Childrens Fund (UNICEF); Washington, DC, USA: 1998. http://www.who.int/nutrition/publications/micronutrients/guidelinesforIronsupplementation.pdf
    Google Scholar
  • 12 French National Health Authorities (Haute Autorité de Santé). Recommendations for clinical practice—Optimal methods for educating pregnant women. 2005 http://www.has-sante.fr/portail/jcms/c_54394/commentmieux-informer-les-femmes-enceintes
    PubMedGoogle Scholar
  • 13 UNICEF/UNU/WHO/MI. UNICEF. Preventing iron deficiency in women and children: Background and consensus on key technical issues and resources for advocacy planning and implementing national programmes. New York, NY, USA: October 1998
    Google Scholar
  • 14 Nestel P, Alnwick D. Iron-micronutrient supplements for young children. Summary and conclusions of a consultation held at UNICEF. Copenhagen, Denmark: August 1996
    Google Scholar
  • 15 Jacobs WLA, Gregory MC. Absorption of iron polymaltose and ferrous sulphate in rats and humans. A comparative study. South African Medical Journal 1979; 55: 1065-1072
    PubMedGoogle Scholar
  • 16 Jacobs P, Fransman D, Coghlan P. Comparative bioavailability of ferric polymaltose and ferrous sulphate in iron-deficient blood donors. Journal of Clinical Apheresis 1993; 8: 89-95
    CrossrefPubMedGoogle Scholar
  • 17 Bordelaa JR, Cicero RE, Dibildox MM et al. IPC versus Iron sulphate in the treatment of iron deficiency in infants. Revues Médicales Pédiatriques 2000; 67: 63-67
    PubMedGoogle Scholar
  • 18 Jacobs P, Johnson G, Wood L. Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose. Journal of Medicine 1984; 15: 367-377
    PubMedGoogle Scholar
  • 19 Ozsoylu S, Ozbek N. Bioavailability of iron. Experimental Hematology 1991; 19: 1065
    PubMedGoogle Scholar
  • 20 Mehta BC. Failure of oral iron therapy in treatment of iron deficiency anemia: pharmaceutical iatrogenic cause. Indian Journal of Medical Sciences 2001; 55: 157-158
    PubMedGoogle Scholar
  • 21 Mehta BC. Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anemia despite continous iron therapy. Journal of the Association of Physicians of India 2002; 50: 279-280
    PubMedGoogle Scholar
  • 22 Bichile SK, Kumar V. Persistent iron deficiency anemia. The Journal of the Association of Physicians of India 2002; 50: 617-618
    PubMedGoogle Scholar
  • 23 Ruiz-Argüelles GJ, Díaz-Hernández A, Manzano C et al. Ineffectiveness of oral iron hydroxide polymaltose in iron-deficiency anemia. Hematology 2007; 12: 255-256
    CrossrefPubMedGoogle Scholar
  • 24 Mehta BC. Ineffectiveness of ironpolymaltose treatment of iron deficiency anaemia. Journal of the Association of Physicians of India 2003; 51: 419-421
    PubMedGoogle Scholar
  • 25 Nielsen P, Gabbe EE, Fischer R et al. Bioavailability of iron from oral ferric polymaltose in humans. Arzneimittel-Forschung/Drug Research 1994; 44: 743-748
    PubMedGoogle Scholar
  • 26 Nielsen P, Kongi R, Fischer R. Efficacy of a prolonged release iron preparation in iron deficiency anaemia. In: Proceedings of the 16th Wonca European Conference 2010
    PubMedGoogle Scholar
  • 27 Langstaff RJ, Geisser P, Heil WG et al. Treatment of iron-deficiency anaemia: a lower incidence of adverse effects with Ferrum Hausmann than ferrous sulphate. British Journal of Clinical Research 1993; 4: 191-198
    PubMedGoogle Scholar
  • 28 Kaltwasser JP, Werner E. Niechzial M/Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations. Arzneimittel-Forschung 1987; 37: 122-129
    PubMedGoogle Scholar
  • 29 Hayhoe FG. Iron preparations for anaemia. BritishMedical Journal 1960; 1: 1195-1197
    PubMedGoogle Scholar
  • 30 Gatenby PBB, Lillie EW. Iron-deficiency anaemia in pregnancy. The Lancet 1955; 265: 740-743
    CrossrefPubMedGoogle Scholar
  • 31 Manasanch J, Castelo-Branco C, Cancelo-Hidalgo MJ et al. Tolerability of different oral iron supplements: a systematic review. In: Proceedings of the 16th Wonca European Conference 2010
    PubMedGoogle Scholar